ProKidney to Participate in TD Cowen’s 43rd Annual Health Care Conference
WINSTON-SALEM, N.C., March 03, 2023 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq:PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that Dr. Tim Bertram, Chief Executive Officer, will present at TD Cowen’s 43rd Annual Health Care Conference on Tuesday March 7, 2023 at 10:30 AM EST.
Related news for (PROK)
- Breaking News: MoBot’s Latest Update as of 09/11/25 10:00 AM
- Today’s Top Performers: MoBot’s Market Review 08/04/25 02:00 PM
- Today’s Top Performers: MoBot’s Market Review 08/04/25 01:00 PM
- ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
- MoBot’s Stock Market Highlights – 07/15/25 08:00 AM